BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23323779)

  • 21. Particulate delivery systems for vaccines: what can we expect?
    Bramwell VW; Perrie Y
    J Pharm Pharmacol; 2006 Jun; 58(6):717-28. PubMed ID: 16734973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymer and nano-technology applications for repair and reconstruction of the central nervous system.
    Cho Y; Borgens RB
    Exp Neurol; 2012 Jan; 233(1):126-44. PubMed ID: 21985867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in pulmonary delivery of nanoparticles.
    Kaur G; Narang RK; Rath G; Goyal AK
    Artif Cells Blood Substit Immobil Biotechnol; 2012 Feb; 40(1-2):75-96. PubMed ID: 21806501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanotechnology based drug delivery system(s) for the management of tuberculosis.
    Pandey R; Khuller GK
    Indian J Exp Biol; 2006 May; 44(5):357-66. PubMed ID: 16708887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Porous nanoparticles in drug delivery systems.
    Arayne MS; Sultana N
    Pak J Pharm Sci; 2006 Apr; 19(2):158-69. PubMed ID: 16751130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in the treatment of neurodegenerative disorders employing nanotechnology.
    Modi G; Pillay V; Choonara YE
    Ann N Y Acad Sci; 2010 Jan; 1184():154-72. PubMed ID: 20146696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Membrane-destabilizing polyanions: interaction with lipid bilayers and endosomal escape of biomacromolecules.
    Yessine MA; Leroux JC
    Adv Drug Deliv Rev; 2004 Apr; 56(7):999-1021. PubMed ID: 15066757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances and challenges of nanotechnology-based drug delivery systems.
    Jiang W; Kim BY; Rutka JT; Chan WC
    Expert Opin Drug Deliv; 2007 Nov; 4(6):621-33. PubMed ID: 17970665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanotechnology for drug and gene therapy: the importance of understanding molecular mechanisms of delivery.
    Labhasetwar V
    Curr Opin Biotechnol; 2005 Dec; 16(6):674-80. PubMed ID: 16263259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potentials of new nanocarriers for dermal and transdermal drug delivery.
    Neubert RH
    Eur J Pharm Biopharm; 2011 Jan; 77(1):1-2. PubMed ID: 21111043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Has nanotechnology led to improved therapeutic outcomes?
    Bosselmann S; Williams RO
    Drug Dev Ind Pharm; 2012 Feb; 38(2):158-70. PubMed ID: 22191583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanotechnological applications for the treatment of neurodegenerative disorders.
    Modi G; Pillay V; Choonara YE; Ndesendo VM; du Toit LC; Naidoo D
    Prog Neurobiol; 2009 Aug; 88(4):272-85. PubMed ID: 19486920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug delivery systems: entering the mainstream.
    Allen TM; Cullis PR
    Science; 2004 Mar; 303(5665):1818-22. PubMed ID: 15031496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different particulate systems--bypass the biological barriers?
    Jătariu AN; Popa M; Peptu CA
    J Drug Target; 2010 May; 18(4):243-53. PubMed ID: 19883240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-penetrating peptides for drug delivery across membrane barriers.
    Foged C; Nielsen HM
    Expert Opin Drug Deliv; 2008 Jan; 5(1):105-17. PubMed ID: 18095931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA nanotechnology-based development of delivery systems for bioactive compounds.
    Mohri K; Nishikawa M; Takahashi Y; Takakura Y
    Eur J Pharm Sci; 2014 Jul; 58():26-33. PubMed ID: 24694593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanoparticles for direct nose-to-brain delivery of drugs.
    Mistry A; Stolnik S; Illum L
    Int J Pharm; 2009 Sep; 379(1):146-57. PubMed ID: 19555750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanotechnology approaches for drug and small molecule delivery across the blood brain barrier.
    Silva GA
    Surg Neurol; 2007 Feb; 67(2):113-6. PubMed ID: 17254859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymeric drug delivery systems for localized cancer chemotherapy.
    De Souza R; Zahedi P; Allen CJ; Piquette-Miller M
    Drug Deliv; 2010 Aug; 17(6):365-75. PubMed ID: 20429844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formulation of therapeutic synthetic polymers for drug and gene delivery.
    Pardridge WM
    Drug Discov Today; 2002 Nov; 7(22):1120-1. PubMed ID: 12546851
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.